The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2008

Filed:

Jan. 10, 2006
Applicants:

Shoji Satoh, Saitama, JP;

Akira Tatsui, Fukushima, JP;

Takeshi Hasegawa, Fukushima, JP;

Hideki Yamada, Saitama, JP;

Shin-ichi Kazayama, Saitama, JP;

Takahiro Morita, Saitama, JP;

Hidekazu Masaki, Saitama, JP;

Atsuo Takahashi, Saitama, JP;

Fumiya Yoneyama, Fukushima, JP;

Tetsuo Kuze, Fukushima, JP;

Yusuke Mizuno, Saitama, JP;

Mizuo Miyazaki, Kyoto, JP;

Shinji Takai, Osaka, JP;

Inventors:

Shoji Satoh, Saitama, JP;

Akira Tatsui, Fukushima, JP;

Takeshi Hasegawa, Fukushima, JP;

Hideki Yamada, Saitama, JP;

Shin-ichi Kazayama, Saitama, JP;

Takahiro Morita, Saitama, JP;

Hidekazu Masaki, Saitama, JP;

Atsuo Takahashi, Saitama, JP;

Fumiya Yoneyama, Fukushima, JP;

Tetsuo Kuze, Fukushima, JP;

Yusuke Mizuno, Saitama, JP;

Mizuo Miyazaki, Kyoto, JP;

Shinji Takai, Osaka, JP;

Assignee:

TOA EIYO Ltd., Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/381 (2006.01); C07D 333/62 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to an N-substituted benzothiophenesulfonamide derivative or a pharmaceutically acceptable salt thereof and applications thereof. Furthermore, it provides an agent for preventing or treating cardiac or circulatory disease and so on caused by abnormal increase of production of angiotensin II or endothelin I based on chymase activity, or by activation of mast cell, and an agent for preventing adhesion after surgery, wherein the agent has a selective inhibitory action on chymase.


Find Patent Forward Citations

Loading…